Learn About Sleep-Heart Interactions on CME Webcast

OSUWexnerbloglogo2014 Learn About Sleep-Heart Interactions on CME Webcast. The interactions between sleep disorders and heart disease are complex and today on MedNet, we’re going to unravel some of that complexity. Joining us in the studio is pulmonologist, sleep specialist, and Professor of Internal Medicine, Dr. Rami Khayat.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS the mechanism of vascular disease in OSA; and DISCUSS the results of recent trials in the treatment of SDB.

You’ll also learn about the following:

  • The relationship between sleep disorders and cardiovascular disorders
  • Epidemiology of obstructive sleep apnea
  • Office-based screening for sleep apnea
  • Screening sleep studies in patients with cardiovascular disease
  • New methods for sleep apnea testing
  • Clues from the 24-hour blood pressure study
  • CPAP versus BiPAP
  • New devices for home non-invasive ventilation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Watch On-line CME Webcast About Uncontrolled Diabetes

OSUWexnerbloglogo2014 Watch On-line CME Webcast About Uncontrolled Diabetes. Hemoglobin A1C measurement is a test that you likely use in your practice every day and when the hemoglobin A1C is very high, it is a sign that the patient’s diabetes has been poorly controlled. On this CME Webcast, we’re going to discuss uncontrolled diabetes. First, to tell us about the medical management of uncontrolled diabetes, endocrinologist and Associate Professor of Internal Medicine, Dr. Kathleen Dungan. And then tell us about the role of diabetic education, nurse and OSU diabetic educator, Janet Zappe.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: COMPARE and contrast the mechanisms of action, efficacy, side effects, and contra-indications of glucose lowering agents for type 2 diabaetes; and UNDERSTAND how to intensify glucose lowering agents to meet individualized patient targets.

You’ll also learn about the following:

  • The ideal hemoglobin A1C level
  • The role of the diabetes educator
  • When to refer
  • Home glucose monitoring
  • Incorporating diabetes education into the primary care practice

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.